Evidence supporting the use of: Vitamin E (natural tocopherols)
For the health condition: Diabetic Retinopathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (as natural tocopherols) has been investigated as a potential adjunct therapy in diabetic retinopathy primarily due to its antioxidant properties. Oxidative stress is a known contributor to the pathogenesis of diabetic retinopathy, and Vitamin E, being a lipid-soluble antioxidant, can help neutralize free radicals and reduce oxidative damage in retinal cells. Several small clinical studies and animal experiments have indicated that Vitamin E supplementation may improve retinal blood flow, reduce vascular leakage, and slow the progression of early diabetic retinal changes. For example, some early trials demonstrated that Vitamin E supplementation improved retinal hemodynamics and reduced proteinuria in diabetic patients, which are indirect measures of microvascular health. Additionally, preclinical studies have shown that Vitamin E can decrease markers of oxidative stress and inflammation in the retina of diabetic animal models.

However, large-scale, high-quality randomized controlled trials (RCTs) in humans are lacking, and meta-analyses have not conclusively established a significant benefit of Vitamin E supplementation in preventing or treating diabetic retinopathy. Furthermore, the American Diabetes Association and major ophthalmology guidelines do not currently recommend Vitamin E as a standard therapy for diabetic retinopathy. Thus, while there is a plausible scientific rationale and some preliminary evidence, the overall strength of evidence remains weak (rated 2/5), and its use is not widely endorsed in clinical practice.

More about Vitamin E (natural tocopherols)
More about Diabetic Retinopathy

Products containing Vitamin E (natural tocopherols)

We currently have no products on Vitabase that contain this ingredient.